List of insiders holdings for ImageneBio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
2021-12-14 20:27:43 | 1,241,935 874,634 |
2,116,569 | Form 4 |
| 2 | Bonita David P Director |
2025-07-30 16:51:45 | 379 773,754 |
774,133 | Form 4 |
| 3 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
2025-07-30 21:30:03 | 0 773,754 |
773,754 | Form 4 |
| 4 | Yarema Kristin Chief Executive Officer |
2025-07-30 21:30:44 | 614,020 0 |
614,020 | Form 4 |
| 5 | Germa Caroline Chief Medical Officer |
2024-03-05 16:05:21 | 579,100 0 |
579,100 | Form 4 |
| 6 | Stampacchia Otello Director |
2025-07-30 16:47:09 | 379 454,982 |
455,361 | Form 4 |
| 7 | Carlson Douglas R COO & EVP of Finance |
2021-03-25 20:06:45 | 439,248 0 |
439,248 | Form 3 |
| 8 | Manfredi Mark President & CEO |
2024-02-02 17:07:47 | 320,000 0 |
320,000 | Form 4 |
| 9 | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
2025-07-29 16:53:05 | 241,800 0 |
241,800 | Form 13D |
| 10 | Santillana Sergio L. Chief Medical Officer |
2023-01-05 16:15:41 | 105,000 0 |
105,000 | Form 4 |
| 11 | Zhang Xiaoyan Michelle Chief Scientific Officer |
2023-01-05 16:15:28 | 105,000 0 |
105,000 | Form 4 |
| 12 | Ecsedy Jeffrey Chief Development Officer |
2024-02-02 17:15:05 | 100,000 0 |
100,000 | Form 4 |
| 13 | Oliveira Francisco Principal Accounting Officer |
2022-02-24 16:54:50 | 71,974 0 |
71,974 | Form 3 |
| 14 | Tessier Maude Chief Business Officer |
2022-02-04 18:09:32 | 40,000 0 |
40,000 | Form 4 |
| 15 | Koehler Maria Director |
2024-06-10 16:15:04 | 17,520 0 |
17,520 | Form 4 |
| 16 | Hughes Owen Director |
2024-06-10 16:15:05 | 17,520 0 |
17,520 | Form 4 |
| 17 | Dukes Iain D. Director |
2024-06-10 16:15:06 | 17,520 0 |
17,520 | Form 4 |
| 18 | Wooster Richard Director |
2024-06-10 16:15:08 | 17,520 0 |
17,520 | Form 4 |
| 19 | FORMELA JEAN FRANCOIS Director |
2024-06-10 16:15:09 | 17,520 0 |
17,520 | Form 4 |
| 20 | Renaud Ronald C JR Director |
2022-06-13 18:09:54 | 13,419 0 |
13,419 | Form 4 |
| 21 | Marango Jotin Chief Financial Officer |
2025-07-29 21:32:38 | 11,146 0 |
11,146 | Form 4 |
| 22 | Butler Erin Principal Accounting Officer |
2025-07-29 19:02:36 | 6,864 0 |
6,864 | Form 4 |